| Whole cohort | Arm-A | Arm-B | p |
---|---|---|---|---|
Cumulative incidence local progression | ||||
 Median time (months) | n.r | n.r | n.r | – |
 1-year (%) | 1.8 (0.9–3.5) | 0.4 (0.1–3.0) | 3.3 (1.6–6.8) | – |
 2-year (%) | 2.5 (1.4–4.4) | 0.9 (0.2–3.4) | 4.2 (2.2–8.0) | – |
 3-year (%) | 2.7 (1.6–4.8) | 1.4 (0.4–4.2) | 4.2 (2.2–8.0) | 0.0581 |
Distant brain failure | ||||
 Median time (months) | 24.9 (18.4-n.r.) | 24.9 (15.6-n.r.) | 24.4 (14.1-n.r.) | – |
 1-year (%) | 36.5 (30.3–43.4) | 35.5 (26.9–45.8) | 37.5 (29.1–47.3) | – |
 2-year (%) | 48.4 (41.4–56.0) | 48.2 (38.2–59.4) | 48.9 (39.4–59.4) | – |
 3-year (%) | 56.2 (48.4–64.2) | 52.5 (41.7–64.2) | 59.8 (48.9–71.0) | 0.3595 |
Disease free survival | ||||
 Median time (months) | 7.3 (6.3–8.8) | 7.8 (5.9–10.5) | 6.9 (6.0–8.4) | – |
 1-year (%) | 31.0 (25.4–36.8) | 32.1 (24.0–40.5) | 29.2 (21.7–37.1) | – |
 2-year (%) | 17.6 (13.1–22.5) | 18.3 (12.0–25.8) | 16.9 (11.0–23.8) | – |
 3-year (%) | 14.3 (10.1–19.0) | 14.0 (8.3–21.2) | 14.4 (9.0–21.1) | 0.5960 |
Overall survival | ||||
 Median time (months) | 17.8 (15.6–22.8) | 18.6 (15.0–25.9) | 16.2 (13.3–23.0) | – |
 1-year (%) | 65.7 (59.5–71.2) | 65.2 (56.0–73.0) | 65.3 (56.3–72.8) | – |
 2-year (%) | 41.1 (34.9–47.1) | 42.3 (33.3–51.1) | 39.1 (30.7–47.4) | – |
 3-year (%) | 30.0 (24.2–36.0) | 29.9 (21.3–38.9) | 29.0 (21.4–37.1) | 0.4087 |
Predictors influencing cumulative incidence local progression | ||||
 Target volume | p < 0.001 HR 1.1 [1.1–1.2] | p = 0.499 HR 1.1 [0.8–1.6] | p = 0.004 HR 1.1 [1.0–1.2] | – |
Predictors influencing distant brain failure | ||||
 Number of lesions | p = 0.01 HR 1.3 [1.1–1.5] | p < 0.01 HR 1.5 [1.1–1.9] | 0.42 HR 1.1 [0.8–1.5] | – |
Predictors influencing disease free survival | ||||
 Patients age | p = 0.001 HR 1.02 [1.01–1.03] | p = 0.029 HR 1.02 [1.00–1.04] | p = 0.022 HR 1.02 [1.00–1.04] | – |
 KPS | p = 0.001 HR 0.7 [0.5–0.8] | p = 0.003 HR 0.6 [0.4–0.8] | p = 0.058 HR 0.71 [0.5–1.0] | – |
 RPA class | p = 0.003 HR 1.8 [1.2–2.7] | p = 0.007 HR 2.1 [1.2–3.6] | p = 0.154 HR 1.5 [0.9–2.7] | – |
 Number of lesions | p = 0.017 HR 1.2 [1.0–1.3] | p = 0.089 1.2 [1.0–1.4] | p = 0.052 1.2 [1.0–1.5] | – |
Predictors influencing overall survival | ||||
 Patients age | p < 0.001 HR 1.03 [1.01–1.04] | p = 0.030 HR 1.02 [1.00–1.05] | p = 0.002 HR 1.03 [1.01–1.05] | – |
 KPS | p =  < 0.001 HR 0.5 [0.4–0.7] | p < 0.002 HR 0.6 [0.4–0.8] | p < 0.001 HR 0.5 [0.3–0.7] | – |
 RPA class | p = 0.05 HR 1.8 [1.2–2.7] | p = 0.106 HR 1.6 [0.9–2.9] | p = 0.046 HR 2.0 [1.0–3.8] | – |
 Number of lesions | p = 0.002 HR 1.3 [1.1–1.4] | p = 0.018 HR 1.3 [1.0–1.5] | p = 0.031 HR 1.3 [1.0–1.6] | – |